Search

everythinglearnresearchcommunity

for

Search:↓

The drug combination significantly reduced epileptic drop attacks in patients.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Increased cell death and reduced cell growth in hair follicles contribute to baldness.

Erenumab significantly reduced migraine days or severity in most patients after 3 months.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Cyproterone acetate reduced hair growth in most hirsute females and made hair softer, thinner, and lighter.

Hair care products reduced hair roughness, a combination of Stemoxydine and Resveratrol increased hair density, fermented mackerel oil promoted hair growth, and genes TERT and Bmi-1 helped create new hair follicles.

Both treatments reduced excessive hair growth in PCOS, but there was no difference in weight, hair score, hormone levels, or insulin resistance.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Tranexamic acid effectively reduced swelling episodes in a girl with a rare form of hereditary angioneurotic edema.

Acupuncture therapy significantly reduced hair loss in women aged 31-50 with female pattern hair loss.

The extract reduced sebum production and promoted hair growth.

Vitamin B6 reduced hair loss in women with diffuse alopecia, but calcium pantothenate had no clear positive effect.

Both oral contraceptives reduced acne effectively and had similar positive effects on skin oiliness and hair growth.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Extended-release valproate effectively reduced seizures and improved quality of life in epilepsy patients over 6 months, with some side effects.

Cyproterone and finasteride reduced hypersexuality but caused serious side effects.

Low-dose oral contraceptives reduced hair growth and testosterone levels in women with polycystic ovary syndrome.

Modified phenol peels effectively reduced stubborn skin pigmentation in patients with Lichen Planus Pigmentosus.

Dihydrotestosterone has a reduced effect on muscle-building in people with testicular feminization syndrome, especially after their gonads are removed.

SH-MSCs gel reduced IL-6 and increased TGF-β, suggesting it could treat alopecia.

Betamethasone dipropionate reduced skin thickness, fish oil increased it, and combined treatment had no significant effect.

The scalp serum reduced scalp discomfort and symptoms without affecting skin moisture loss.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The topical treatment reduced hair loss and improved hair growth in patients with certain types of hair loss.

Both emollients effectively reduced itching and improved skin moisture in xerotic eczema.

Finasteride significantly reduced tics and obsessive-compulsive symptoms in Tourette syndrome patients.